175 related articles for article (PubMed ID: 37152948)
1. ECSIT is essential for RANKL-induced stimulation of mitochondria in osteoclasts and a target for the anti-osteoclastogenic effects of estrogens.
Marques-Carvalho A; Sardão VA; Kim HN; Almeida M
Front Endocrinol (Lausanne); 2023; 14():1110369. PubMed ID: 37152948
[TBL] [Abstract][Full Text] [Related]
2. Estrogens decrease osteoclast number by attenuating mitochondria oxidative phosphorylation and ATP production in early osteoclast precursors.
Kim HN; Ponte F; Nookaew I; Ucer Ozgurel S; Marques-Carvalho A; Iyer S; Warren A; Aykin-Burns N; Krager K; Sardao VA; Han L; de Cabo R; Zhao H; Jilka RL; Manolagas SC; Almeida M
Sci Rep; 2020 Jul; 10(1):11933. PubMed ID: 32686739
[TBL] [Abstract][Full Text] [Related]
3. Dual Oxidase Maturation Factor 1 Positively Regulates RANKL-Induced Osteoclastogenesis via Activating Reactive Oxygen Species and TRAF6-Mediated Signaling.
Cheon YH; Lee CH; Jeong DH; Kwak SC; Kim S; Lee MS; Kim JY
Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32899248
[TBL] [Abstract][Full Text] [Related]
4. A novel RANKL-targeted flavonoid glycoside prevents osteoporosis through inhibiting NFATc1 and reactive oxygen species.
Hong G; Chen Z; Han X; Zhou L; Pang F; Wu R; Shen Y; He X; Hong Z; Li Z; He W; Wei Q
Clin Transl Med; 2021 May; 11(5):e392. PubMed ID: 34047464
[TBL] [Abstract][Full Text] [Related]
5. Peroxiredoxin-6 Negatively Regulates Bactericidal Activity and NF-κB Activity by Interrupting TRAF6-ECSIT Complex.
Min Y; Wi SM; Shin D; Chun E; Lee KY
Front Cell Infect Microbiol; 2017; 7():94. PubMed ID: 28393051
[TBL] [Abstract][Full Text] [Related]
6. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
Michael H; Härkönen PL; Väänänen HK; Hentunen TA
J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275
[TBL] [Abstract][Full Text] [Related]
7. TRAF family member-associated NF-κB activator (TANK) induced by RANKL negatively regulates osteoclasts survival and function.
Wu M; Wang Y; Deng L; Chen W; Li YP
Int J Biol Sci; 2012; 8(10):1398-407. PubMed ID: 23139637
[TBL] [Abstract][Full Text] [Related]
8. Xanthotoxin prevents bone loss in ovariectomized mice through the inhibition of RANKL-induced osteoclastogenesis.
Dou C; Chen Y; Ding N; Li N; Jiang H; Zhao C; Kang F; Cao Z; Quan H; Luo F; Xu J; Dong S
Osteoporos Int; 2016 Jul; 27(7):2335-2344. PubMed ID: 26809192
[TBL] [Abstract][Full Text] [Related]
9. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
Valverde P; Tu Q; Chen J
J Bone Miner Res; 2005 Sep; 20(9):1669-79. PubMed ID: 16059638
[TBL] [Abstract][Full Text] [Related]
10. Anti-IFN-γ Antibody Promotes Osteoclastogenesis in Human Bone Marrow Monocyte-Derived Macrophages Co-Cultured with Tuberculosis-Activated Th1 Cells.
Deng J; Sun D; Luo F; Zhang Q; Chen F; Xu J; Zhang Z
Cell Physiol Biochem; 2018; 49(4):1512-1522. PubMed ID: 30205409
[TBL] [Abstract][Full Text] [Related]
11. Oestradiol and osteoclast differentiation: Effects on p53 and mitochondrial metabolism.
Marques-Carvalho A; Silva B; Pereira FB; Kim HN; Almeida M; Sardão VA
Eur J Clin Invest; 2024 Jun; 54(6):e14195. PubMed ID: 38519718
[TBL] [Abstract][Full Text] [Related]
12. Siglec-15 is a potential therapeutic target for postmenopausal osteoporosis.
Kameda Y; Takahata M; Mikuni S; Shimizu T; Hamano H; Angata T; Hatakeyama S; Kinjo M; Iwasaki N
Bone; 2015 Feb; 71():217-26. PubMed ID: 25460183
[TBL] [Abstract][Full Text] [Related]
13. TLR signalling augments macrophage bactericidal activity through mitochondrial ROS.
West AP; Brodsky IE; Rahner C; Woo DK; Erdjument-Bromage H; Tempst P; Walsh MC; Choi Y; Shadel GS; Ghosh S
Nature; 2011 Apr; 472(7344):476-80. PubMed ID: 21525932
[TBL] [Abstract][Full Text] [Related]
14. Polyphyllin VII attenuated RANKL-induced osteoclast differentiation via inhibiting of TRAF6/c-Src/PI3K pathway and ROS production.
Zhou L; Song H; Zhang Y; Ren Z; Li M; Fu Q
BMC Musculoskelet Disord; 2020 Feb; 21(1):112. PubMed ID: 32075617
[TBL] [Abstract][Full Text] [Related]
15. Licorice isoliquiritigenin suppresses RANKL-induced osteoclastogenesis in vitro and prevents inflammatory bone loss in vivo.
Zhu L; Wei H; Wu Y; Yang S; Xiao L; Zhang J; Peng B
Int J Biochem Cell Biol; 2012 Jul; 44(7):1139-52. PubMed ID: 22521613
[TBL] [Abstract][Full Text] [Related]
16. DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis.
Cai X; Xing J; Long CL; Peng Q; Humphrey MB
J Bone Miner Res; 2017 Nov; 32(11):2207-2218. PubMed ID: 28650106
[TBL] [Abstract][Full Text] [Related]
17. Nrf2 deficiency induces oxidative stress and promotes RANKL-induced osteoclast differentiation.
Hyeon S; Lee H; Yang Y; Jeong W
Free Radic Biol Med; 2013 Dec; 65():789-799. PubMed ID: 23954472
[TBL] [Abstract][Full Text] [Related]
18. Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.
Li C; Yang Z; Li Z; Ma Y; Zhang L; Zheng C; Qiu W; Wu X; Wang X; Li H; Tang J; Qian M; Li D; Wang P; Luo J; Liu M
J Bone Miner Res; 2011 Mar; 26(3):644-56. PubMed ID: 20814972
[TBL] [Abstract][Full Text] [Related]
19. Regulation of RANKL-induced osteoclastogenesis by RING finger protein RNF114.
Lin B; Ke Q; Leaman DW; Goel V; Agarwal A
J Orthop Res; 2018 Jan; 36(1):159-166. PubMed ID: 28708287
[TBL] [Abstract][Full Text] [Related]
20. Puerarin alleviates osteoporosis in the ovariectomy-induced mice by suppressing osteoclastogenesis via inhibition of TRAF6/ROS-dependent MAPK/NF-κB signaling pathways.
Xiao L; Zhong M; Huang Y; Zhu J; Tang W; Li D; Shi J; Lu A; Yang H; Geng D; Li H; Wang Z
Aging (Albany NY); 2020 Nov; 12(21):21706-21729. PubMed ID: 33176281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
